Hu Y, Zhang W, Chen Z, Wu X, Xue S, Mao Y
Front Neurol. 2025; 15:1529944.
PMID: 39866517
PMC: 11757116.
DOI: 10.3389/fneur.2024.1529944.
Tran L, Freeman K, Lunzer M, Portoghese P, Haskell-Luevano C
ACS Pharmacol Transl Sci. 2025; 8(1):225-244.
PMID: 39816790
PMC: 11729433.
DOI: 10.1021/acsptsci.4c00604.
Sirbu C
Adv Neurobiol. 2024; 35:381-395.
PMID: 38874733
DOI: 10.1007/978-3-031-45493-6_19.
Cox B, Toll L
Adv Drug Alcohol Res. 2024; 2:10115.
PMID: 38390618
PMC: 10880772.
DOI: 10.3389/adar.2022.10115.
Fairbanks C, Peterson C
Front Pain Res (Lausanne). 2023; 4:960389.
PMID: 38028425
PMC: 10646403.
DOI: 10.3389/fpain.2023.960389.
Molecular basis of opioid receptor signaling.
Che T, Roth B
Cell. 2023; 186(24):5203-5219.
PMID: 37995655
PMC: 10710086.
DOI: 10.1016/j.cell.2023.10.029.
Chemical tools for the opioids.
Duque M, Vallavoju N, Woo C
Mol Cell Neurosci. 2023; 125:103845.
PMID: 36948231
PMC: 10247539.
DOI: 10.1016/j.mcn.2023.103845.
Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy.
Lohman R, Tupally K, Kandale A, Cabot P, Parekh H
Front Pharmacol. 2023; 14:1150313.
PMID: 36937883
PMC: 10020352.
DOI: 10.3389/fphar.2023.1150313.
The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder.
Margolis E, Moulton M, Lambeth P, OMeara M
Neuropharmacology. 2022; 225:109376.
PMID: 36516892
PMC: 10548835.
DOI: 10.1016/j.neuropharm.2022.109376.
Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham J, Markovic T, Massaly N, Moron J
Front Syst Neurosci. 2022; 16:1014768.
PMID: 36341476
PMC: 9628214.
DOI: 10.3389/fnsys.2022.1014768.
Integrative Hedonic and Homeostatic Food Intake Regulation by the Central Nervous System: Insights from Neuroimaging.
Campos A, Port J, Acosta A
Brain Sci. 2022; 12(4).
PMID: 35447963
PMC: 9032173.
DOI: 10.3390/brainsci12040431.
Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands.
Sharma K, Cassell R, Meqbil Y, Su H, Blaine A, Cummins B
RSC Med Chem. 2021; 12(11):1958-1967.
PMID: 34825191
PMC: 8597420.
DOI: 10.1039/d1md00025j.
Current understanding of the neurobiology of opioid use disorder: An overview.
Moningka H, Lichenstein S, Yip S
Curr Behav Neurosci Rep. 2021; 6(1):1-11.
PMID: 34485022
PMC: 8412234.
DOI: 10.1007/s40473-019-0170-4.
An Effective and Safe Enkephalin Analog for Antinociception.
Viswanadham K, Bottger R, Hohenwarter L, Nguyen A, Rouhollahi E, Smith A
Pharmaceutics. 2021; 13(7).
PMID: 34206631
PMC: 8308721.
DOI: 10.3390/pharmaceutics13070927.
Biased ligands at opioid receptors: Current status and future directions.
Che T, Dwivedi-Agnihotri H, Shukla A, Roth B
Sci Signal. 2021; 14(677).
PMID: 33824179
PMC: 7611221.
DOI: 10.1126/scisignal.aav0320.
Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.
Cahill C, Tejeda H, Spetea M, Chen C, Liu-Chen L
Handb Exp Pharmacol. 2021; 271:3-21.
PMID: 33754230
PMC: 9013522.
DOI: 10.1007/164_2021_433.
Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.
Gintzler A, Liu N
Transl Res. 2021; 234:31-42.
PMID: 33567346
PMC: 8217383.
DOI: 10.1016/j.trsl.2021.02.002.
Polysomnographic Correlates for the Risk of Relapse in Detoxified Opiate-Misuse Patients.
Rady A, Mekky J, Moulokheya T, Elsheshai A
Neuropsychiatr Dis Treat. 2020; 16:3187-3196.
PMID: 33376334
PMC: 7764935.
DOI: 10.2147/NDT.S284337.
Opioid Receptor Regulation of Neuronal Voltage-Gated Calcium Channels.
Weiss N, Zamponi G
Cell Mol Neurobiol. 2020; 41(5):839-847.
PMID: 32514826
PMC: 11448596.
DOI: 10.1007/s10571-020-00894-3.
Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.
Fricker L, Margolis E, Gomes I, Devi L
Mol Pharmacol. 2020; 98(2):96-108.
PMID: 32487735
PMC: 7330675.
DOI: 10.1124/mol.120.119388.
